Solstice Advanced Materials Moves Ahead of Sector

Solstice Advanced Materials Moves Ahead of Sector

June 1, 2026

NEW YORK, June 1, 2026, 15:04 (EDT)

  • Solstice shares gained 0.9% in afternoon trade, sticking close to the session highs.
  • The change is set before a June 4 nuclear-business webinar and the June 10 dividend payout.
  • Margins are still in focus as first-quarter profit dropped even though sales were up.

Solstice Advanced Materials shares gained Monday afternoon, with the stock up 0.9% at $84.95 as of 2:49 p.m. EDT. Solstice traded between $82.93 and $85.13. The move put Solstice ahead of the broader materials group, as investors seemed to focus more on nuclear and electronic-materials growth than on margin pressures.

Timing is key here. Solstice is set to hold a nuclear-business webinar on June 4, which will let the Honeywell spin-off talk details on one of its quicker growth areas. Investors on record as of May 27 will also pick up a $0.075 per share dividend when the payout lands June 10.

Solstice shares aren’t cheap, which has fueled debate around the stock. On Monday, the company held a market cap of about $13.5 billion and traded near its 52-week high of $90.80, market data showed.

Solstice started regular trading on Nasdaq as SOLS in October after Honeywell finished the spin of its Advanced Materials unit. Honeywell shares continued to trade as HON.

First-quarter results were mixed. Net sales climbed 10% to $991 million on strength in refrigerants, nuclear and electronic materials. Net income dropped 37% to $85 million. Adjusted EBITDA stayed about flat at $249 million as margins squeezed.

Solstice CEO David Sewell said in May the “macroeconomic outlook remains uncertain,” adding the company still expects to hit its 2026 targets. Solstice kept its full-year net sales guidance at $3.9 billion to $4.1 billion and adjusted EBITDA of $975 million to $1.025 billion. PR Newswire

Sewell told the earnings call demand for chips and data centers was driving sales. He said Solstice was “selling everything we can make” at the Spokane site, which makes materials for advanced electronics. Chief Financial Officer Tina Pierce said Middle East disruptions to inputs have been “minimal.” Pierce also said Solstice expects to cover price and cost through the rest of the year. Investing

Analyst views on the stock are divided. Six analysts polled by Investing.com call it a consensus “Buy,” with two buy ratings and four holds, no sells. The average 12-month target is $88.17. RBC Capital kept its Outperform and a $94 price target after the May earnings, pointing to adjusted EBITDA beating its and the Street’s forecasts. Investing

Peers moved in different directions. Qnity Electronics dropped 3.6%, while Chemours, a maker of low-GWP refrigerants, added 0.1%. Honeywell, the former parent, was off 0.7%. The Materials Select Sector SPDR ETF lost 0.3%, so Solstice’s rise was modest but clear, not a big outlier.

Profit is less certain even as sales rise. Solstice said in the first quarter, margins were hit by a move to refrigerants with lower global warming potential and by higher R&D spending. The company warned that if switching to these products takes longer, or if planned second-quarter maintenance outages turn out worse, investors could start to look past nuclear and AI demand and question earnings quality.

Mateusz Brzeziński

Mateusz Brzeziński is a financial and technology journalist at Bez-kabli.pl, covering stocks, artificial intelligence, semiconductors and global market developments. He graduated from the Prague University of Economics and Business in the Czech Republic and previously worked in financial analysis before moving into business journalism. His reporting focuses on the companies, technologies and market trends shaping the global economy.

Stock Market Today

  • A2 Milk (ASX:A2M) falls 24.3% in 2025 as investors weigh outlook
    July 26, 2026, 12:02 AM EDT. A2 Milk Company Ltd (ASX:A2M) shares have tumbled 24.3% since early 2025 as investors look closer at the business. Based in New Zealand, A2M sells dairy products with the A2-only protein type, marketed as easier to digest than A1. The company outsources much of its production and has a key supply deal with Synlait Milk for making infant formula. Consumer staples names like A2M are known for resilience and less volatility in slower economies but A2M's dividend yield is still just 0.28% over five years-pointing to some company-specific risks. The price-to-sales ratio is at 4.01 now, higher than its five-year average of 3.44, signaling a premium even with falling shares. Investors are weighing A2M's growth narrative against the sector, with the ASX Consumer Staples Index lagging the wider market.